A platform for research: civil engineering, architecture and urbanism
LONG-TERM SAFETY AND EFFECTIVENESS OF LURASIDONE IN SCHIZOPHRENIA: RESULTS OF A 22 MONTH, OPEN-LABEL EXTENSION STUDY
LONG-TERM SAFETY AND EFFECTIVENESS OF LURASIDONE IN SCHIZOPHRENIA: RESULTS OF A 22 MONTH, OPEN-LABEL EXTENSION STUDY
LONG-TERM SAFETY AND EFFECTIVENESS OF LURASIDONE IN SCHIZOPHRENIA: RESULTS OF A 22 MONTH, OPEN-LABEL EXTENSION STUDY
Annual meeting; 165th, American Psychiatric Association ; 2012 ; Philadelphia, PA
2012-01-01
180 pages
Conference paper
English
© Metadata Copyright the British Library Board and other contributors. All rights reserved.
SWITCHING FROM OLANZAPINE TO LURASIDONE: RESULTS FROM A 6-MONTH OPEN LABEL EXTENSION STUDY
British Library Conference Proceedings | 2012
|EFFECT OF 12 MONTHS OF LURASIDONE ON WEIGHT IN SUBJECTS WITH SCHIZOPHRENIA
British Library Conference Proceedings | 2012
|Long Term Effectiveness of Treatments of Sandstone
British Library Conference Proceedings | 1995
|Westmoreland signs long-term deal extension in Canada
Online Contents | 2016